Ticker
GTH

Price
4.03
Stock movement up
+0.01 (0.12%)
Company name
Genetron Holdings Ltd
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Diagnostics & Research
Market cap
121.56M
Ent value
202.45M
Price/Sales
0.22
Price/Book
0.14
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
34.17%
3 year return
-58.11%
5 year return
-
10 year return
-
Last updated: 2024-06-13

DIVIDENDS

GTH does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.22
Price to Book0.14
EV to Sales0.37

FINANCIALS

Per share

Loading...
Per share data
Current share count30.20M
EPS (TTM)-22.69
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)547.47M
Gross profit (TTM)306.52M
Operating income (TTM)-658.67M
Net income (TTM)-701.25M
EPS (TTM)-22.69
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)55.99%
Operating margin (TTM)-120.31%
Profit margin (TTM)-128.09%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash327.55M
Net receivables432.18M
Total current assets989.76M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets1.30B
Accounts payable53.69M
Short/Current long term debt161.10M
Total current liabilities350.10M
Total liabilities408.44M
Shareholder's equity894.92M
Net tangible assets864.06M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)0.00
Capital expenditures (TTM)0.00
Free cash flow (TTM)0.00
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-78.36%
Return on Assets-53.80%
Return on Invested Capital-68.34%
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.02
Daily high4.05
Daily low4.02
Daily Volume412K
All-time high91.92
1y analyst estimate8.88
Beta0.50
EPS (TTM)-22.69
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
GTHS&P500
Current price drop from All-time high-95.62%-0.02%
Highest price drop-97.51%-56.47%
Date of highest drop29 Sep 20229 Mar 2009
Avg drop from high-70.21%-11.29%
Avg time to new high63 days13 days
Max time to new high786 days1805 days
COMPANY DETAILS
GTH (Genetron Holdings Ltd) company logo
Marketcap
121.56M
Marketcap category
Small-cap
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
Employees
1154
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner